Medifoxamine

From Wikipedia, the free encyclopedia

Medifoxamine
Systematic (IUPAC) name
N,N-dimethyl-2,2-bis(phenoxy)ethanamine
Identifiers
CAS number 32359-34-5
ATC code  ?
PubChem 36109
Chemical data
Formula C16H19NO2 
Mol. mass 257.328 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?
Legal status
Routes  ?

Medifoxamine is an antidepressant drug which inhibits the reuptake of dopamine[1] and acts as an agonist at the 5HT2A and 5HT2C receptors.[2] It was used mainly in France,[3] but was withdrawn following problems with hepatotoxicity.[4]




Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[edit] References

  1. ^ Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. British Journal of Clinical Pharmacology. 1992 Sep;34(3):269-71. PMID 1389953
  2. ^ Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) L'Encéphale. 1994 Jul-Aug;20(4):427-35. PMID 7988407
  3. ^ Mitchell PB. Novel French antidepressants not available in the United States. Psychopharmacology Bulletin. 1995;31(3):509-19. PMID 8668756
  4. ^ Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D. Hepatic tolerance of atypical antipsychotic drugs. (French). L'Encéphale. 2002 Nov-Dec;28(6 Pt 1):542-51. PMID 12506267
v • d • e
Psychoanaleptics: antidepressants (N06A)
MAOIs
RIs
Medifoxamine • Phenmetrazine • Vanoxerine • TCAs (Amineptine)
SSREs
AAs